
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Income Statement | ||||||
Revenue | $1.7B | $1.6B | $1.4B | $340.1M | $284M | |
Gross Profit | $562.7M | $441.2M | $468.4M | $99.7M | $113.4M | |
Operating Income | $323.5M | $229.1M | $276.8M | $45.7M | $62.6M | |
EBITDA | $438.4M | $71.2M | -$238M | -$19M | $72.5M | |
Diluted EPS | $5.28 | -$3.11 | -$9.74 | -$1.54 | $0.56 |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $642.4M | $732.8M | $716.3M | $669.2M | $530M | |
Total Assets | $2.3B | $2.5B | $2.8B | $2.6B | $2.1B | |
Current Liabilities | $224.5M | $551.7M | $278.8M | $351.7M | $264.6M | |
Total Liabilities | $1.7B | $1.8B | $2B | $2B | $1.8B | |
Total Equity | $661.1M | $686.1M | $725.7M | $568.2M | $234.6M | |
Total Debt | $1.3B | $1.3B | $1.5B | $1.5B | $1.4B |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $294.4M | $187.7M | $166.1M | -$12.1M | $25.4M | |
Cash From Investing | -$519.2M | -$96.1M | -$74.7M | -$16.3M | -$11.5M | |
Cash From Financing | $88.8M | -$70.9M | -$104.6M | $23.4M | -$11M | |
Free Cash Flow | $154.1M | $86.7M | $95.1M | -$28.7M | $15.4M |
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.
In the current month, NGVT has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The NGVT average analyst price target in the past 3 months is $54.25.
According to analysts, the consensus estimate is that Ingevity share price will rise to $54.25 per share over the next 12 months.
Analysts are divided on their view about Ingevity share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ingevity is a Sell and believe this share price will drop from its current level to $47.00.
The price target for Ingevity over the next 1-year time period is forecast to be $54.25 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
According to Wall Street analysts, the consensus rating for Ingevity is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
You can purchase shares of Ingevity via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ingevity shares.
Ingevity was last trading at $46.30 per share. This represents the most recent stock quote for Ingevity. Yesterday, Ingevity closed at $45.49 per share.
In order to purchase Ingevity stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.